Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease
2017 · New England Journal of Medicine · 2,521 citations
https://doi.org/10.1056/nejmoa1701719
C
Christopher J. Gibson
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
261
Papers
12.5K
Citations
44
h-index
79
i10-index
Christopher J. Gibson is an academic researcher from Merck & Co., Inc., Rahway, NJ, USA (United States). The author has contributed to research in topics: Acute Myeloid Leukemia Research & Cancer Genomics and Diagnostics & Myeloproliferative Neoplasms: Diagnosis and Treatment. The author has an h-index of 44, co-authored 222 publications.
ORCID: 0000-0002-3700-5310Papers by this author
worksPD-L2 Expression in Human Tumors: Relevance to Anti-PD-1 Therapy in Cancer
2017 · Clinical Cancer Research · 588 citations
https://doi.org/10.1158/1078-0432.ccr-16-1761
Turning Gray: The Natural History of Lung Cancer Over Time
2008 · Journal of Thoracic Oncology · 178 citations
https://doi.org/10.1097/jto.0b013e31817c9230
Distinct genetic pathways define pre-malignant versus compensatory clonal hematopoiesis in Shwachman-Diamond syndrome
2021 · Nature Communications · 168 citations
https://doi.org/10.1038/s41467-021-21588-4
Clonal hematopoiesis is associated with adverse outcomes in multiple myeloma patients undergoing transplant
2020 · Nature Communications · 160 citations
https://doi.org/10.1038/s41467-020-16805-5
Allogeneic Hematopoietic Cell Transplantation Improves Outcome in Myelodysplastic Syndrome Across High-Risk Genetic Subgroups: Genetic Analysis of the Blood and Marrow Transplant Clinical Trials Network 1102 Study
2023 · Journal of Clinical Oncology · 64 citations
https://doi.org/10.1200/jco.23.00866
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat